The American College of Radiology (ACR) provided the White House with recommendations on regulating and monitoring AI technologies in clinical radiology.
Key Details
- 1ACR submitted feedback to the White House Office of Science and Technology Policy on AI integration in clinical settings.
- 2Key focus areas include AI oversight, reimbursement strategies, and government transparency.
- 3ACR stressed enhancing FDA oversight, especially for adaptive and continuous learning AI systems.
- 4They recommended real-world and post-market monitoring to address issues like AI model drift.
- 5ACR highlighted national AI registries such as Assess-AI for ongoing model performance tracking and data privacy concerns.
Why It Matters
These recommendations will help shape national policy around safe, effective, and transparent use of AI in radiology, directly impacting radiologists, vendors, and patients. Real-world tracking and better regulation are critical for trustworthy AI adoption in medical imaging.
Source
Radiology Business
Related News
•HealthExec
FDA Eases Path for AI in Clinical Decision Support and Healthcare Innovation
FDA publishes new guidance to promote innovation in general wellness and clinical decision support, impacting medical AI including radiology.
•AuntMinnie
FDA Guidance May Expand LLM Use in Radiology CDS
FDA updates its guidance, potentially enabling broader adoption of LLM-based clinical decision support software in radiology.
•AuntMinnie
Citizen Petition Proposes Streamlined FDA Pathway for Radiology AI
A petition urges the FDA to allow certain radiology AI software updates via postmarket study requirements instead of new 510(k) applications.